LL
Insider
Laura Sepp-Lorenzino
EVP, Chief Scientific OfficerLaura Sepp-Lorenzino (EVP, Chief Scientific Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Intellia Therapeutics, Inc. (NTLA). The largest single filing was $109K of NTLA (8,966 sh × $12.18, as filed), executed Jan 3 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$109K
shares × price, as filed
Last traded
Jan 3 2025
Filed Jan 7 2025
Median ADV $62.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $109K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
NTLARecent filings
NTLASALE
Intellia Therapeutics, Inc.
View filing →
$109K8,966 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET